Montefiore Medical Center, Bronx, NY;
Johannes Gutenberg, Mainz, Germany;
Albert Einstein College of Medicine, Bronx
Background: A novel histological risk assessment of squamous cell carcinoma (SCC) is predictive of overall survival (OS) in patients with cancer of the oral cavity. The purpose of the current study is to validate this risk scoring on a new cohort. Our target sample size is an estimated 344 patients. We present an interim analysis on 163 patients with primary upper aerodigestive tract SCC (UADT-SCC).
Brandwein-Gensler M, Thielken A, Smith RV, Negassa A, Sarta C, Owen R, Schiff B, Smith JC, Prystowsky M. P137 Validation of Our Histological Risk Assessment Model: An Interim Analysis. Arch Otolaryngol Head Neck Surg. 2006;132(8):892. doi:10.1001/archotol.132.8.892-b